PoliticsMostly Factual · factual reporting (3 of 5)Outlet ratings by Media Bias/Fact Check 
The GLP-1 blind spot: Why the FDA’s new eye stroke warning matters
Eric Wargotz, opinion contributor·The Hill·November 19, 2026

It forces the medical community to treat these therapies with clinical gravity instead of casual enthusiasm.
Read the full story at The Hill →